Question Bank › Fixed price, unfixed volume

Fixed price, unfixed volume

Fixed price, unfixed volume: the company is locked into a rate while the amount it can sell against it is climbing

Calls Tested
499
Answered YES
33
Hit Rate
6.6%
rare by design

OPKO Health, Inc. (OPK) — this company's answers

NO on the Q1 2022 call 2022-05-09 D
The model's full reasoning — Q1 2022 call → NOThe question asks whether management describes a situation where the price/rate/fee is already fixed or contractually set, while the quantity of business at that rate is currently rising or about to rise, so results scale with volume. Let me scan the transcript for such a situation. Key candidates: 1. COVID testing - volume declining, not rising. 2. Somatrogon/Ngenla - Pfizer partnership. Milestones triggered by launches. Royalty/gross profit share not yet forecasted. The $85 million milestone is a one-time payment, not a per-unit rate. 3. 4Kscore - FDA approved, growth plan to capture reimbursement coverage - this is about getting coverage, i.e., price/rate not yet settled. 4. Scarlet Health - digital health platform, adding clients like Teladoc, MVP Healthcare. This is about adding volume, but is the rate fixed? Not clearly described as such. 5. BioReference core business - growing volumes, but pricing with payers? They mention preferred status with Aetna and UnitedHealthcare - that's about being in-network, but not necessarily fixed rates. Let me look more carefully. The question asks for ONE coherent situation with both halves: rate settled AND volume rising now. The ModeX acquisition - R&D, not a rate/volume business. The Sema4/GeneDx transaction - they sold it, not relevant. The Pfizer milestones - $85 million triggered by launches in Japan and Germany. This is a milestone payment, not a per-unit rate. The gross profit share is not yet forecasted. So no. The 4Kscore - "we have developed a growth plan to capture additional reimbursement coverage from the commercial health plans" - this is about getting rates set, not rates already set. Scarlet Health - "We are receiving added reimbursement from payers as a specifically covered service for over 85 million patients" - this suggests rates are being set/covered. And they're adding clients like Teladoc. But is the rate fixed? It says "receiving added reimbursement" - this is about getting coverage, which is about getting rates. The volume is growing (Teladoc, MVP Healthcare). But the rate side - is it settled? It seems like they're still in the process of getting reimbursement coverage. The question asks if the rate is already settled and not the open variable. Here, reimbursement coverage is being added - that suggests rates are still being negotiated/obtained.

← Back to the full OPK analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe a situation in which THE PRICE, RATE, OR FEE THE COMPANY EARNS ON A MEANINGFUL PART OF ITS BUSINESS IS ALREADY FIXED OR CONTRACTUALLY SET, while THE QUANTITY OF BUSINESS THE COMPANY CAN EARN THAT RATE ON IS CURRENTLY RISING OR ABOUT TO RISE — so that the company's results scale with volume it is now adding rather than with a price it must go negotiate? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation with both halves present as a present-tense reality: (1) THE RATE SIDE IS ALREADY SETTLED. Management indicates that what the company gets paid per unit of business — per unit, ton, barrel, load, room, seat, subscriber, case, procedure, contract, day, transaction, member, licence, or whatever the natural unit is — is already established and not the open variable: it is contracted, tariffed, tolled, regulated, indexed, hedged, standardized, fixed by a long-term agreement, set by a fee schedule or take-or-pay structure, or otherwise locked for the relevant period. Any genuine expression counts, and the form varies widely: long-term offtake, supply, charter, lease, or capacity agreements at agreed rates; regulated or approved tariffs and reimbursement rates; hedged or pre-sold output; a standardized price list or fee-per-unit the company applies across customers; committed contracts where the counterparty pays a set amount per unit regardless of market swings. What matters is that management is not describing price as the thing it is fighting over — the economics per unit are, for practical purposes, already known. (2) THE VOLUME SIDE IS OPEN AND MOVING UP NOW. Management describes the amount of business that will be earned at that settled rate as currently increasing, or about to increase from things already in motion — more units produced, shipped, served, treated, transported, hosted, subscribed, processed, or otherwise delivered — grounded in real activity or real commitments already in place: capacity being brought up, sites or lines being added, customers already signed and ramping, work already awarded and beginning to be performed, utilization climbing, output expanding. The increase must rest on something already happening or already secured, not on hoped-for demand, market recovery, or price improvement. AND management should convey, directly or plainly in substance, that the results just reported reflect the LOWER volume level — so the reported period understates what the same settled economics produce at the volume now arriving — and that the volume step-up is meaningful relative to the company's current size rather than a routine increment. The essence is ONE phenomenon: the uncertain variable in this business has been reduced to how much it can put through, because what each unit earns is no longer in question. That makes the company's near-term outcome a matter of throughput arithmetic that management can already partly see, while the reported financials still describe the smaller throughput. Answer NO if the company's economics per unit are the open question — prices being negotiated, market prices it passively receives and hopes will rise, rates under competitive pressure, discounting, or reimbursement not yet determined. NO if the improvement management points to is chiefly higher prices or better rates rather than more volume at settled rates. NO if the volume increase is only hoped for, forecast, in pipeline, or dependent on approvals, financing, or decisions not yet obtained. NO if the volume growth described is routine and ordinary for this company, with no sense that it steps the business beyond its current level. NO if the settled-rate business is a trivial part of the company, or if the fixed pricing is simply the permanent, unchanging structure of the industry with no volume step-up attached to it. NO if volumes are described as flat, declining, or at capacity with no room to grow. NO if the reported results already fully reflect the higher volume, leaving no gap. NO if management is chiefly explaining weak volumes, unfavorable contract terms, hedges that are hurting the company, or rates being reset downward. NO if the situation appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
NOAH Noah Holdings Limited Q1 2024 2024-05-30 D
AES The AES Corporation Q1 2024 2024-05-03 C+
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
MNKD MannKind Corporation Q4 2023 2024-02-27 C
PUMP ProPetro Holding Corp. Q4 2023 2024-02-21 C+
JLL Jones Lang LaSalle Incorporated Q3 2023 2023-11-02 F
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
SLF Sun Life Financial Inc. Q1 2023 2023-05-12 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
ESEA Euroseas Ltd. Q4 2022 2023-02-15 C+
CEIX CONSOL Energy Inc. Q4 2022 2023-02-07 B
CHE Chemed Corporation Q3 2022 2022-11-01 B+
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
KFY Korn Ferry Q4 2022 2022-06-22 B
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
RNW ReNew Energy Global Plc Q2 2022 2021-11-18 C
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
ALB Albemarle Corporation Q3 2018 2018-11-08 B
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
HLX Helix Energy Solutions Group, Inc. Q1 2018 2018-04-24 B+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
FI Fiserv, Inc. Q4 2017 2018-02-27 C
CPK Chesapeake Utilities Corporation Q3 2017 2017-11-10 A
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
FIX Comfort Systems USA, Inc. Q1 2017 2017-04-30 A
ABR Arbor Realty Trust, Inc. Q4 2016 2017-03-03 B+
GPOR Gulfport Energy Corporation Q4 2016 2017-02-14 A

How the model reasoned

ABR · Q4 2016 → YESThe question is about whether management describes a situation where the price/rate/fee is already fixed, but the quantity/volume is rising, so results scale with volume. YES The transcript shows management describing the Agency Business servicing portfolio at $13.6 billion with a fixed 48 basis point weighted average servicing fee that is already contracted and recurring. They explicitly note the portfolio is growing through recent originations, including $700 million closed in December, which will drive higher servicing income in Q 1. Management states they expect the portfolio to generate over $65 million annually and references growth from 2015 levels, indicating the reported Q4 results reflect a lower average volume during the quarter while the settled economics now scale with the increasing volume arriving in Q1.
FIX · Q1 2017 → YESThe question is about whether management describes a situation where the price/rate/fee is already fixed, but the quantity/volume is rising, so results scale with volume. YES The transcript shows management describing a situation where pricing is stable and contracts (backlog) lock in rates, while volume is rising through backlog growth and upcoming organic work. The Q1 results reflect lower seasonal volume, with the backlog supporting higher throughput ahead. This fits the criteria of settled rates on meaningful contracted business with 13% backlog increase driving volume step-up.
CHE · Q3 2022 → YESThe question is about whether management describes a situation where the price/rate/fee is already fixed, but the quantity/volume is rising, so results scale with volume. YES Management describes Medicare reimbursement rates as already fixed by regulation (CMS), with the volume side now rising through a first significant expansion of clinical staff and patient capacity since the pandemic, plus strengthening admissions and weekly ADC growth in the second half. The reported quarter reflects lower volume (ADC down 4.

More from the question bank

The lull that never cameProven engine, fuel already in the tankDoing it our way nowSizing the constraint out loudRicher on arrival: the business now flowing Front, middle, and back of the business all All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.